APA (7th ed.) Citation

Compter, I., Eekers, D., Hoeben, A., Rouschop, K., Reymen, B., Ackermans, L., . . . Lambin, P. (2019). 425P - CHLOROBRAIN phase IB trial: The addition of chloroquine, an autophagy inhibitor, to concurrent radiation and temozolomide for newly diagnosed glioblastoma. Annals of Oncology, 30, v154. https://doi.org/10.1093/annonc/mdz243.035

Chicago Style (17th ed.) Citation

Compter, I., et al. "425P - CHLOROBRAIN Phase IB Trial: The Addition of Chloroquine, an Autophagy Inhibitor, to Concurrent Radiation and Temozolomide for Newly Diagnosed Glioblastoma." Annals of Oncology 30 (2019): v154. https://doi.org/10.1093/annonc/mdz243.035.

MLA (9th ed.) Citation

Compter, I., et al. "425P - CHLOROBRAIN Phase IB Trial: The Addition of Chloroquine, an Autophagy Inhibitor, to Concurrent Radiation and Temozolomide for Newly Diagnosed Glioblastoma." Annals of Oncology, vol. 30, 2019, p. v154, https://doi.org/10.1093/annonc/mdz243.035.